Continuous weak-affinity immunosensing

S Ohlson1, C Jungar, M Strandh

  • 1Department of Natural Sciences, University of Kalmar, SE-391 29 Kalmar, Sweden. sten.ohlson@ng.hik.se

Trends in Biotechnology
|February 1, 2000
PubMed

Insights

Continuous immunosensing is now possible by leveraging weak biological interactions. This novel approach eliminates the need for regeneration, enabling truly on-line molecular evaluation.

Area of Science:

  • Biochemistry
  • Biotechnology
  • Analytical Chemistry

Background:

  • Biological systems frequently utilize numerous weak interactions.
  • These readily reversible interactions are fundamental to biological processes.
  • Exploiting these interactions offers potential for novel sensing technologies.

Purpose of the Study:

  • To develop a continuous immunosensing device based on weak biological interactions.
  • To demonstrate the feasibility of on-line molecular evaluation without regeneration.

Main Methods:

  • Utilized surface plasmon resonance (SPR) to study a model system.
  • Employed a set of weak monoclonal antibodies targeting a specific carbohydrate epitope.

Main Results:

  • Successfully demonstrated continuous immunosensing using weak antibody-epitope interactions.
  • The developed system operates effectively without requiring regeneration steps.

Conclusions:

  • Weak biological interactions can be reliably used for continuous immunosensing.
  • This regeneration-free approach enables truly on-line molecular monitoring.
  • The principle has broad applicability for continuous molecule evaluation across various fields.

Related Concept Videos

Immunoglobulin-like Cell Adhesion Molecules01:31

Immunoglobulin-like Cell Adhesion Molecules

Immunoglobulin-like cell adhesion molecules or Ig-CAMs are a versatile group of cell surface glycoproteins belonging to the immunoglobulin protein superfamily. Ig-CAMs possess the characteristic immunoglobulin protein domains and other domains such as the fibronectin type III domain. The Ig domains are glycosylated to varying degrees in different Ig-CAMs.
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Enzyme-Linked Immunosorbent Assay01:33

Enzyme-Linked Immunosorbent Assay

In 1971, Peter Perlman and Eva Engvall developed an Enzyme-linked immunosorbent assay (ELISA or EIA). ELISA differs from western blot in that the assays are conducted in microtiter plates or in vivo rather than on an absorbent membrane.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen.  Enzyme-substrate reaction allows the antigen to be visualized or quantified.
Immunocytochemistry and Immunohistochemistry01:22

Immunocytochemistry and Immunohistochemistry

Immunocytochemistry (ICC) and immunohistochemistry (IHC) are techniques that use antibodies to check for specific proteins or antigens in a sample. The technique was first published by Albert Coons in 1941 to detect the presence of pneumococcal antigen in tissue sections from mice infected with Pneumococcus. Immunocytochemistry helps localization of proteins or antigens in individual cells like blood cells, stem cells, etc., while immunohistochemistry does the same for tissue samples.
These...